Manager/Sr. Manager, Investor Relations & Corporate Communications

About this role

<p><strong>About Avalyn</strong></p> <p>Avalyn aims to transform the treatment paradigm for pulmonary fibrosis and other serious, rare respiratory diseases. The company is advancing optimized inhaled formulations of established antifibrotic medicines designed to deliver drug directly to the lungs, enhance local efficacy, and reduce systemic side effects. Avalyn’s AP01 program is an optimized inhaled formulation of pirfenidone currently being evaluated in MIST, a global Phase 2b clinical trial in patients with progressive pulmonary fibrosis (PPF). AP01 has demonstrated encouraging safety and clinical activity across Phase 1b and an ongoing, multi-year open-label extension trial, with long-term data supporting the potential to preserve lung function while improving tolerability relative to historical oral pirfenidone. Avalyn’s AP02 program is an optimized inhaled formulation of nintedanib currently being evaluated in AURA-IPF, a global Phase 2 clinical trial in patients with idiopathic pulmonary fibrosis (IPF). Avalyn is also advancing AP03, an inhaled fixed-dose combination of pirfenidone and nintedanib, designed to deliver multiple antifibrotic mechanisms through a single lung-targeted platform. By leveraging its proprietary drug-device approach and deep expertise in rare respiratory disease development, Avalyn aims to establish a new standard of care in pulmonary fibrosis through inhaled, lung-targeted therapies. For more information, please visit <a class="web" href="https://www.globenewswire.com/Tracker?data=CUTV0SsG-Ei_lqUFR1s2Q9IFeC3BztUf2Q9VzwR--g1bp8pG5_5zAveC1plWtXdlqm_iFd4sbp6T0rZk0HdLmArRmLnA9Y8ktgQ5-MSe9AFNL9HulxYyNLq4bHe1mfDxPm2y90XOzJ0iACoQdCGleje6soZiUuCwhDxEr1VQjgRBBrAq4bFXbJkrVhzJS8_gsjTotqKyQVCpjI_pauDMWihPoxh5z2UVZouuiXVs57i60x3w3SzyJLuV-GY9ZxHuNa0gOfZTiqF9PzxJfOsr5Q==" target="_blank"><u>avalynpharma.com</u></a> and follow the company on <a class="web" href="https://www.globenewswire.com/Tracker?data=4P2X2kH6BMyR2KxZfJ2MXh0ZUOoR38a69EFti2TlA36ngqdKMtKF5-j7OecQdK76POEQqSdtzWNigv6bkSNFFmJiZ8MtoBbfONRa-pWIolzXPs1ltjLnHeGe0vyolYgNAjU3gfPV_Hvl7H58OI5Exbmk3Wq7-Qs97BgII9k3MaiTYe2qPC6xF3bKgvcyi-TqVSXu-iAmomfd39bWJqo41t97hHXQS5gOD2_vu21HwDa0EUVDPTfazlgoOdioGTpbEU6fDieVck9cnoROpPmFQw==" target="_blank"><u>LinkedIn</u></a>.</p> <p><strong>Position Overview</strong></p> <p>The Manager/Senior Manager, Investor Relations & Corporate Communications will provide hands-on execution across a broad range of investor relations and external communications initiatives. This is a writing- and production-intensive role that is ideal for a communications professional who thrives on delivering high-quality work across multiple workstreams. This individual is highly organized and detail-oriented, possesses exceptional writing and editing skills, and has a solid understanding of the biotech development landscape. We are seeking an individual who is eager to grow professionally while making a meaningful impact during an important stage of the company's development. This role reports to the Head of IR & Corporate Communications.</p> <p><strong>Key Responsibilities</strong></p> <p><strong><em>Corporate Narrative & Messaging</em></strong></p> <ul> <li>Partner with the Head of IR & Corporate Communications to develop and maintain the company's core messaging framework, ensuring consistency across external materials and internal stakeholders</li> <li>Draft and adapt key messages for investors, media, patients, partners, patients, and other external stakeholders</li> <li>Assist in preparing messaging for pipeline milestones and clinical updates, including data readouts and regulatory updates</li> <li>Coordinate with external communications and investor relations agencies to ensure alignment, timely execution, and consistent messaging</li> </ul> <p><strong><em>External Communications</em></strong></p> <ul> <li>Assist in drafting press releases across all corporate announcement types—clinical data, regulatory updates, milestones, partnerships, and executive news—for Senior Director and legal review</li> <li>Support media relations efforts including coordinating journalist inquiries, preparing background materials, and maintaining media contact lists</li> <li>Help prepare executive spokespeople for media engagements, including compiling briefing documents and Q&A materials</li> <li>Support communications surrounding clinical data readouts and medical conference presentations, coordinating logistics and drafting materials in partnership with Clinical, Competitive Intelligence, and Medical Affairs teams</li> <li>Maintain a library of clinical data communications precedents, peer company disclosure benchmarks, and key message archives</li> </ul> <p><strong><em>Social Media & Digital Communications</em></strong></p> <ul> <li>Execute the company's day-to-day social media presence across LinkedIn and other relevant platforms, including drafting posts, maintaining the content calendar, and scheduling content</li> <li>Coordinate content development across functions (R&D, Patient Advocacy, Medical Affairs, and HR) and draft social content highlighting corporate milestones, clinical progress, conference activity, and company culture, ensuring appropriate reviews and approvals</li> <li>Support brand content efforts in partnership with HR, including team spotlights, hiring announcements, and culture-forward posts</li> <li>Help develop…